This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.Need a new registration confirmation email? Click here

Monsanto Company (MON): Today's Featured Chemicals Laggard

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

Monsanto Company (
MON) pushed the Chemicals industry lower today making it today's featured Chemicals laggard. The industry as a whole closed the day down 0.7%. By the end of trading, Monsanto Company fell $1.32 (-1.4%) to $89.75 on average volume. Throughout the day, 2.6 million shares of Monsanto Company exchanged hands as compared to its average daily volume of 2.7 million shares. The stock ranged in price between $89.50-$91.48 after having opened the day at $91.07 as compared to the previous trading day's close of $91.07. Other companies within the Chemicals industry that declined today were:
American Vanguard Corporation (
AVD), down 10.4%,
Cereplast (
CERP), down 7.9%,
Oil-Dri Corporation of America (
ODC), down 7.4%, and
Landec Corporation (
LNDC), down 7.2%.

EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Monsanto Company, together with its subsidiaries, provides agricultural products for farmers. It operates in two segments, Seeds and Genomics, and Agricultural Productivity. Monsanto Company has a market cap of $48.41 billion and is part of the basic materials sector. The company has a P/E ratio of 24, above the S&P 500 P/E ratio of 17.7. Shares are up 30% year to date as of the close of trading on Tuesday. Currently there are 11 analysts that rate Monsanto Company a buy, one analyst rates it a sell, and five rate it a hold.

TheStreet Ratings rates Monsanto Company as a
buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, notable return on equity, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income.